Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fernando De la Garza-Salazar (Fernando De la Garza Salazar)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Annals of hematology

Case reports in infectious diseases

Journal of thrombosis and thrombolysis

Scientific reports

Hospital Universitario Dr José Eleuterio González

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario Dr José Eleuterio González Mar 1o 2020

Mexico

Resident :: Hematología

Publications

Fernando De la Garza-Salazar, Andrés Gómez-De León, Guillermo José Ruiz Argüelles, Perla Rocio Colunga-Pedraza
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia. Annals of hematology 102 (2) (2023)
Fernando De la Garza-Salazar, Andrés Gómez-De León, Guillermo José Ruiz Argüelles, Perla Rocio Colunga-Pedraza
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia. Annals of hematology 102 (2) (2023)
Fernando De la Garza-Salazar, Andrés Gómez-De León, Guillermo José Ruiz Argüelles, Perla Rocio Colunga-Pedraza
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia. Annals of hematology (2023)
Fernando De la Garza-Salazar, Perla Rocio Colunga-Pedraza, Edgar Ulises Coronado-Alejandro, César Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez, Guillermo José Ruiz Argüelles
Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease. British journal of haematology (2023)
Fernando De la Garza-Salazar, Andrés Gómez-De León, Guillermo José Ruiz Argüelles, Perla Rocio Colunga-Pedraza
Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia. Annals of hematology 102 (2) (2023)
Fernando De la Garza-Salazar, Perla Rocio Colunga-Pedraza, Guillermo José Ruiz Argüelles
Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: A proof-of-concept case study. British journal of clinical pharmacology (2022)
Perla Rocio Colunga-Pedraza, Samantha P Peña-Lozano, Ernesto Sánchez-Rendón, Fernando De la Garza-Salazar, Julia Esther Colunga-Pedraza, Andrés Gómez-De León, Paola Santana-Hernández, Olga Graciela Cantú-Rodríguez, Guillermo José Ruiz Argüelles
Oseltamivir as rescue therapy for persistent, chronic, or refractory immune thrombocytopenia: a case series and review of the literature. Journal of thrombosis and thrombolysis 54 (2) (2022)
Fernando De la Garza-Salazar, Maria Elena Romero-Ibarguengoitia, José Ramón Azpiri López, Arnulfo González-Cantú
Optimizing ECG to detect echocardiographic left ventricular hypertrophy with computer-based ECG data and machine learning. PloS one 16 (11) (2021)
Fernando De la Garza-Salazar, Diana Lorena Lankenau-Vela, Bertha Cadena-Nuñez, Arnulfo González-Cantú, Maria Elena Romero-Ibarguengoitia
The Effect of Functional and Intra-Coronary Imaging Techniques on Fluoroscopy Time, Radiation Dose and Contrast Volume during Coronary Angiography. Scientific reports 10 (1) (2020)
Fernando De la Garza-Salazar, Elías Abraham Rodríguez Díaz, Arnulfo González-Cantú, José Ramón Azpiri López, Mauricio Kuri Ayache, Maria Elena Romero-Ibarguengoitia
Diagnostic utility of the electrocardiographic left ventricular hypertrophy criteria in specific populations. Acta cardiologica 76 (3) (2020)
Fernando De la Garza-Salazar, Carlos Alejandro Cortéz-Hernández, Horacio Decanini-Arcaute, Adrián Camacho-Ortíz
Acute Seronegative Toxoplasma gondii Hepatitis Allergic to First-Line Treatment. Case reports in infectious diseases 2018 (2018)

Fernando De la Garza-Salazar.css-eqlu8i{font-size:small;padding-left:4px;} (Fernando De la Garza Salazar)

Publication Activity (10 Years)

Top Topics

Top Venues

Fernando De la Garza-Salazar (Fernando De la Garza Salazar)